Atlas Trials

To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder

Clinical trial NCT04917315 · COMPLETED

Trial details

NCT number
NCT04917315
Sponsor
Jeil Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Overactive Bladder
Start date
2020-05-21
Primary completion
2021-08-18
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.